Company intelligence / Profile preview

Wendeng Jinye

Weihai, Shandong, China

Ownership: Private
Development stage: Other

Overview

Shandong Wendeng Jinye Pharmaceutical is a Chinese pharmaceutical company specializing in the manufacture of traditional Chinese medicines and chemical drug formulations. Based in Weihai, Shandong, the company produces a variety of dosage forms including tablets, capsules, and granules. Its product line is well-known for respiratory treatments, most notably its Compound Liquorice Tablets, as well as various vitamin supplements. The firm operates under Chinese Good Manufacturing Practice (GMP) standards to provide essential medicines to the domestic market.

Therapeutic areas: HematologyImmunologyNephrologyWomen's HealthOtherCardiovascularEndocrinologyNeurologyInfectious DiseasesPulmonologyRare DiseasesGastroenterologyMetabolic DisordersPsychiatryOncology
Modalities: Small moleculeTraditional Chinese Medicine
Industry: Biotech

Beyond the preview

Go deeper on Wendeng Jinye.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wendeng Jinye.

Explore the full profile